Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John J. Hines is active.

Publication


Featured researches published by John J. Hines.


Radiation Research | 1992

Cellular Kinetics, Dosimetry, and Radiobiology of α-Particle Radioimmunotherapy: Induction of Apoptosis

Roger M. Macklis; Johann Y. Lin; Beverly A. Beresford; Robert W. Atcher; John J. Hines; John L. Humm

Though clinical results for radioimmunoconjugate therapy of most common epithelial tumors have been disappointing, dramatic responses have been observed repeatedly in the treatment of high- and low-grade malignant lymphomas. This high clinical responsiveness after radioimmunoconjugate therapy sometimes appears to be out of proportion to the calculated radiation dose absorbed by the lymphoma tissue. Here we describe some key aspects of the kinetics, dosimetry, and cellular radiobiology of murine lymphoma cells exposed to 212Bi-radiolabeled alpha-particle-emitting immunoconjugates specific for the differentiation antigen Thy 1.2. Approximately 25 cell-bound alpha-particle-emitting immunoconjugates per target cell were required to reduce clonogenic survival by 90% (the radiobiological D10). Serial kinetic analyses of the antibody and radioisotope components of the immunoconjugates revealed significant levels of dechelation and up to 7.5% cellular internalization of the isotope. Cellular radiation dosimetry performed by Monte Carlo computer simulation of alpha-particle energy deposition patterns based on the observed radiopharmacokinetics showed that the D10 resulted from approximately four alpha-particle traversals through the nucleus, corresponding to an absorbed radiation dose of approximately 0.95 Gy to the cell nucleus. Electron micrographs and DNA gel studies of murine lymphoma cells undergoing radioimmunoconjugate therapy in vivo and in vitro demonstrated bizarre blebbing patterns, condensation of chromosomal material, and internucleosomal DNA fragmentation patterns characteristic of programmed cell death (apoptosis). We conjecture that the efficacy of radioimmunoconjugates against responsive cell types may be the result of passive DNA damage by ionizing radiation and the initiation of apoptosis in response to radioimmunotherapy.


International Journal of Radiation Oncology Biology Physics | 1989

Resident's essay award: Alpha particle radio-immunotherapy: Animal models and clinical prospects

Roger M. Macklis; William D. Kaplan; James L.M. Ferrara; Robert W. Atcher; John J. Hines; Steven J. Burakoff; C. Norman Coleman

Short-lived isotopes that emit alpha particles have a number of physical characteristics which make them attractive candidates for radioimmunotherapy. Among these characteristics are high linear energy transfer and correspondingly high cytotoxicity; particle range limited to several cell diameters from the parent atom; low potential for repair of alpha-induced DNA damage; and low dependence on dose rate and oxygen enhancement effects. This report reviews the synthesis, testing and use in animal models of an alpha particle emitting radioimmunoconjugate constructed via the noncovalent chelation of Bismuth-212 to a monoclonal IgM antibody specific for the murine T cells/neuroectodermal surface antigen, Thy 1.2. These 212Bi-anti-Thy 1.2 immunoconjugates are capable of extraordinary cytotoxicity in vitro, requiring approximately three 212Bi-labeled conjugates per target cell to suppress 3H-thymidine incorporation to background levels. The antigen specificity afforded by the monoclonal antibody contributes a factor of approximately 40 to the radiotoxicity of the immunoconjugate. Animals inoculated with a Thy 1.2+ malignant ascites were cured of their tumor in an antigen-specific fashion by intraperitoneal doses of approximately 200 microCi per mouse. Alpha particle emitting radioimmunoconjugates show great potential for regional and intracavitary molecular radiotherapy.


Radiation Research | 1993

Morphological, biochemical, and molecular changes in endothelial cells after alpha-particle irradiation

Michael T. Speidel; Barton Holmquist; Amin I. Kassis; John L. Humm; Robert M. Berman; Robert W. Atcher; John J. Hines; Roger M. Macklis

The response of cultured bovine aortic endothelial (BAE) cells after exposure to alpha-particle radiation from chelated 212Bi has been evaluated. The results suggest that even relatively high doses of alpha-particle radiation from 212Bi (20-72 Gy) cause only minor acute changes in the morphology of BAE cells (light and electron microscopy) under conditions of confluent monolayer growth. Significant morphological changes can be detected in cells that detach from the monolayer, though it is unclear whether these changes represent a genuine response to irradiation or reflect the causes or effects of monolayer detachment with the consequent loss of intercellular biochemical communication. After alpha-particle irradiation (20-40 Gy) angiotensin-converting-enzyme activity was not detectable in the monolayer culture medium but was significantly decreased within the cell monolayer. Neutral-elution-assay data demonstrated that DNA double-strand-break (DSB) damage occurred in these cells and that about 35% of the DSBs were repairable.


Archive | 1985

Isotopic generator for bismuth-212 and lead-212 from radium

Arnold M. Friedman; John J. Hines


Archive | 1998

Process and apparatus for the production of BI-213 cations

E. Philip Horwitz; John J. Hines; R. Chiarizia; Mark L. Dietz


Archive | 1989

Colloid labelled with radionuclide and method

John J. Hines


Archive | 2001

Method for isolating and purifying 90Y From 90strontium in multi-curie quantities

E. Philip Horwitz; John J. Hines


The Journal of Nuclear Medicine | 1990

Iodine-125-NRLU-10 kinetic studies and bismuth-212-NRLU-10 toxicity in LS174T multicell spheroids

Virginia K. Langmuir; John J. Hines; Martin W. Brechbiel


Archive | 1997

Process and apparatus for the production of BI-212 and a use thereof

Jacob Rotmensch; Jenny L. Whitlock; John J. Hines; Paul V. Harper


Archive | 1991

Method of treating inflammatory diseases using a radiolabeled ferric hydroxide calloid

John J. Hines

Collaboration


Dive into the John J. Hines's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Philip Horwitz

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Jacob Rotmensch

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James L.M. Ferrara

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

John L. Humm

Memorial Sloan Kettering Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge